{"id":361124,"date":"2025-08-30T16:14:37","date_gmt":"2025-08-30T16:14:37","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-immunocore-holdings\/"},"modified":"2025-08-30T16:14:37","modified_gmt":"2025-08-30T16:14:37","slug":"how-to-buy-immunocore-holdings","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-immunocore-holdings\/","title":{"rendered":"Immunocore Holdings plc (IMCR) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Immunocore Holdings plc (IMCR) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334072,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-361124","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Immunocore Holdings plc (IMCR) Hisseleri Nas\u0131l Al\u0131n\u0131r - Immunocore Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Immunocore Holdings plc (IMCR) Hisseleri Nas\u0131l Al\u0131n\u0131r - Immunocore Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Immunocore Holdings plc (IMCR) hisselerini nas\u0131l alaca\u011f\u0131n\u0131z\u0131 tam yat\u0131r\u0131m rehberimizle \u00f6\u011frenin. G\u00fcncel fiyat, riskler ve 2025-2030 b\u00fcy\u00fcme potansiyelini ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Immunocore Holdings plc (IMCR) hisselerini nas\u0131l alaca\u011f\u0131n\u0131z\u0131 tam yat\u0131r\u0131m rehberimizle \u00f6\u011frenin. G\u00fcncel fiyat, riskler ve 2025-2030 b\u00fcy\u00fcme potansiyelini ke\u015ffedin."},"intro":"Keskin kanser imm\u00fcnoterapisine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Immunocore Holdings (IMCR), devrim niteli\u011findeki ImmTAX platformlar\u0131yla hassas t\u0131bb\u0131n gelece\u011fini temsil ediyor. Bu \u0130ngiliz-Amerikan biyoteknoloji \u00f6nc\u00fcs\u00fc, FDA onayl\u0131 TCR terapisiyle hayatlar\u0131 de\u011fi\u015ftirdi ve daha yeni ba\u015fl\u0131yorlar. Bu hissenin neden dikkatinizi hak etti\u011fini ve b\u00fcy\u00fcme hikayelerinin bir par\u00e7as\u0131 nas\u0131l olabilece\u011finizi ke\u015ffedelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"Keskin kanser imm\u00fcnoterapisine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Immunocore Holdings (IMCR), devrim niteli\u011findeki ImmTAX platformlar\u0131yla hassas t\u0131bb\u0131n gelece\u011fini temsil ediyor. Bu \u0130ngiliz-Amerikan biyoteknoloji \u00f6nc\u00fcs\u00fc, FDA onayl\u0131 TCR terapisiyle hayatlar\u0131 de\u011fi\u015ftirdi ve daha yeni ba\u015fl\u0131yorlar. Bu hissenin neden dikkatinizi hak etti\u011fini ve b\u00fcy\u00fcme hikayelerinin bir par\u00e7as\u0131 nas\u0131l olabilece\u011finizi ke\u015ffedelim."},"body_html":"<h2>\ud83d\udcc8 Immunocore Hissesi: G\u00fcncel Fiyat ve Piyasa Konumu<\/h2> <p>30 A\u011fustos 2025 itibar\u0131yla, Immunocore Holdings plc (IMCR) NASDAQ borsas\u0131nda <strong>32,65 $<\/strong> fiyatla i\u015flem g\u00f6r\u00fcyor. \u015eirket, dalgal\u0131 biyoteknoloji sekt\u00f6r\u00fcnde ola\u011fan\u00fcst\u00fc bir dayan\u0131kl\u0131l\u0131k g\u00f6stererek <strong>883 milyon $<\/strong> g\u00fc\u00e7l\u00fc nakit pozisyonunu korurken etkileyici gelir art\u0131\u015f\u0131 sa\u011flad\u0131.<\/p> <p><strong>Takviminize not edin: 5 Kas\u0131m 2025<\/strong>, IMCR yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in kesinlikle kritik bir tarih. \u015eirketin 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klad\u0131\u011f\u0131 g\u00fcn ve tarihsel olarak bu a\u00e7\u0131klamalar \u00f6nemli fiyat hareketlerine neden oluyor.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 IMCR Hissesini Nas\u0131l Hareket Ettirir<\/h3> <p>Immunocore, analist beklentilerini a\u015fma konusunda \u00fcn kazanm\u0131\u015ft\u0131r. 2025 2. \u00e7eyrek sonu\u00e7lar\u0131, hisse ba\u015f\u0131na -0,20 $ kazan\u00e7 g\u00f6stererek, -0,21 $ olan konsens\u00fcs tahminlerini 0,01 $ a\u015fm\u0131\u015ft\u0131r. Daha da etkileyici olan, \u00f6nceki \u00e7eyrekte hisse ba\u015f\u0131na 0,10 $ kazan\u00e7 sa\u011flayarak beklenen -0,35 $ de\u011ferini %128,57 olumlu s\u00fcrprizle a\u015fmalar\u0131d\u0131r (<a href=\"https:\/\/tickernerd.com\/stock\/imcr-forecast\/\">Tickernerd<\/a>).<\/p> <p>Desen a\u00e7\u0131k: Immunocore beklentileri a\u015ft\u0131\u011f\u0131nda, piyasa onlar\u0131 \u00f6d\u00fcllendiriyor. 2025 2. \u00e7eyrek geliri 130,65 milyon $'a ula\u015farak %30 y\u0131ll\u0131k art\u0131\u015f g\u00f6sterdi ve 122,96 milyon $ olan konsens\u00fcs tahminlerini ge\u00e7ti (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/IMCR\/earnings\/\">MarketBeat<\/a>).<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu ve Volatilite Analizi<\/h2> <p>Immunocore hisseleri son alt\u0131 ayda zorlu ama nihayetinde istikrarl\u0131 bir yol izledi. Hisse, <strong>52 haftal\u0131k 23,15 $ ile 39,33 $ aral\u0131\u011f\u0131nda<\/strong> i\u015flem g\u00f6rd\u00fc ve mevcut fiyat bu aral\u0131\u011f\u0131n ortalar\u0131na yak\u0131n konumda (<a href=\"https:\/\/www.macrotrends.net\/stocks\/charts\/IMCR\/immunocore-holdings\/stock-price-history\">Macrotrends<\/a>).<\/p> <p><strong>\u00d6nemli volatilite bilgileri:<\/strong><\/p> <ul> <li>G\u00fcnl\u00fck volatilite son hafta ortalamas\u0131 <strong>%2,47<\/strong><\/li> <li>Haftal\u0131k volatilite <strong>%4,5<\/strong> olup biyoteknoloji sekt\u00f6r ortalamas\u0131 %10,6'n\u0131n olduk\u00e7a alt\u0131ndad\u0131r<\/li> <li>Hisse son ayda sadece <strong>%47 ye\u015fil g\u00fcn<\/strong> g\u00f6sterirken fiyat volatilitesi %10,27'dir<\/li> <\/ul> <p>Baz\u0131 a\u015fa\u011f\u0131 y\u00f6nl\u00fc bask\u0131lara ra\u011fmen, IMCR <strong>35,63 $ teknik deste\u011fini<\/strong> hacim birikimine dayanarak koruyor ve test edilirse potansiyel al\u0131m f\u0131rsat\u0131 sunuyor (<a href=\"https:\/\/stockinvest.us\/stock\/IMCR\">StockInvest<\/a>).<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <h3>K\u0131sa Vadeli Projeksiyonlar (2025-2026)<\/h3> <p>2025 i\u00e7in analistler <strong>ortalama fiyat hedefi 47,23 $<\/strong> \u00f6ng\u00f6r\u00fcyor; iyimser senaryolar 65,65 $'a, muhafazakar tahminler ise 28,80 $ civar\u0131na ula\u015fabilir (<a href=\"https:\/\/stockscan.io\/stocks\/IMCR\/forecast\">Stockscan<\/a>). 7 uzman\u0131n olu\u015fturdu\u011fu mevcut analist konsens\u00fcs\u00fc <strong>\"Al\" notu ve ortalama hedef 57 $<\/strong> olup, mevcut seviyelerden %74,58 potansiyel y\u00fckseli\u015f anlam\u0131na geliyor.<\/p> <h3>Orta ve Uzun Vadeli Tahmin<\/h3> <ul> <li><strong>2026<\/strong>: 50-60 $ aral\u0131\u011f\u0131na do\u011fru b\u00fcy\u00fcme e\u011filiminin devam etmesi bekleniyor<\/li> <li><strong>2028<\/strong>: \u00dcr\u00fcn hatt\u0131 olgunla\u015ft\u0131k\u00e7a 70-85 $ aral\u0131\u011f\u0131na ula\u015fmas\u0131 \u00f6ng\u00f6r\u00fcl\u00fcyor<\/li> <li><strong>2030<\/strong>: Platform geni\u015flemesi ve pazar penetrasyonuna dayanarak 90,85 $ tahmin ediliyor<\/li> <\/ul> <p><strong>Sonu\u00e7: UZUN VADEL\u0130 G\u00dc\u00c7L\u00dc ALIM<\/strong>. G\u00fc\u00e7l\u00fc gelir art\u0131\u015f\u0131, geni\u015fleyen \u00fcr\u00fcn hatt\u0131 ve devasa hedef pazarlar IMCR'yi sab\u0131rl\u0131 sermaye i\u00e7in cazip bir f\u0131rsat haline getiriyor.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Y\u00fcksek RSI<\/strong>: Mevcut RSI14 de\u011feri <strong>81<\/strong> a\u015f\u0131r\u0131 al\u0131m ko\u015fullar\u0131n\u0131 g\u00f6steriyor<\/li> <li><strong>K\u00e2rl\u0131l\u0131k zorluklar\u0131<\/strong>: -0,41 negatif EPS ve -26,71 ileriye d\u00f6n\u00fck F\/K oran\u0131<\/li> <li><strong>Klinik deneme riskleri<\/strong>: Faz 3 denemeleri do\u011fas\u0131 gere\u011fi belirsizlik ta\u015f\u0131r<\/li> <li><strong>Reg\u00fclasyon engelleri<\/strong>: FDA onaylar\u0131 biyoteknolojide \u00f6ng\u00f6r\u00fclemez olabilir<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>Gelir patlamas\u0131<\/strong>: KIMMTRAK sat\u0131\u015flar\u0131 2. \u00e7eyrekte %30 y\u0131ll\u0131k art\u0131\u015fla 98,0 milyon $ oldu<\/li> <li><strong>Nakit kalesi<\/strong>: 883 milyon $ nakit rezervi 5+ y\u0131l finansman sa\u011fl\u0131yor<\/li> <li><strong>\u00dcr\u00fcn hatt\u0131 ilerlemesi<\/strong>: Faz 3 TEBE-AM denemesi 2026 ilk yar\u0131s\u0131nda tamamlanmaya uygun<\/li> <li><strong>Sekt\u00f6r r\u00fczgarlar\u0131<\/strong>: Kanser imm\u00fcnoterapisi pazar\u0131 y\u0131lda %15 b\u00fcy\u00fcyor<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %5 veya daha az\u0131n\u0131 temsil eden pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fc ile ba\u015flay\u0131n<\/li> <li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n<\/strong>: Zamanlama hatalar\u0131n\u0131 \u00f6nlemek i\u00e7in ayl\u0131k sabit tutarlarda yat\u0131r\u0131m yap\u0131n<\/li> <li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong>: Potansiyel giri\u015f noktalar\u0131 i\u00e7in 5 Kas\u0131m kazan\u00e7lar\u0131n\u0131 izleyin<\/li> <li><strong>Uzun vadeli d\u00fc\u015f\u00fcn\u00fcn<\/strong>: Biyoteknoloji yat\u0131r\u0131mlar\u0131 3-5 y\u0131l zaman ufku gerektirir<\/li> <\/ol> <p>Mizahi yorum: \"IMCR ticareti yapmak klinik deneme izlemek gibidir - %90 bekleyi\u015f, %10 heyecan, ama i\u015fe yarad\u0131\u011f\u0131nda ger\u00e7ekten i\u015fe yarar!\"<\/p> <h2>\u2705 Immunocore Holdings plc (IMCR) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir ticaret platformu se\u00e7in<\/td><td>NASDAQ eri\u015fimi ve makul \u00fccretler sundu\u011fundan emin olun<\/td><\/tr> <tr><td>2<\/td><td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td><td>Genellikle kimlik ve adres kan\u0131t\u0131 gerektirir<\/td><\/tr> <tr><td>3<\/td><td>Fon yat\u0131r\u0131n<\/td><td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>4<\/td><td>\"IMCR\" aramas\u0131 yap\u0131n<\/td><td>\u015eirket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td><td>Giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td><\/tr> <tr><td>6<\/td><td>\u0130nceleyin ve onaylay\u0131n<\/td><td>Son i\u015flem \u00f6ncesi komisyon oranlar\u0131n\u0131 kontrol edin<\/td><\/tr> <tr><td>7<\/td><td>Pozisyonunuzu izleyin<\/td><td>Stop-loss ve kar hedefleri belirleyin<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Uygun?<\/h2> <p>Pocket Option, hisse senedi yat\u0131r\u0131m\u0131n\u0131 herkes i\u00e7in eri\u015filebilir k\u0131lar:<\/p> <ul> <li><strong>Minimum depozito sadece 5 $<\/strong> - stratejileri risksiz test etmek i\u00e7in m\u00fckemmel<\/li> <li><strong>1 dakikal\u0131k KYC s\u00fcreci<\/strong> - herhangi bir kimlik belgesi y\u00fckleyin ve hemen i\u015flem yapmaya ba\u015flay\u0131n<\/li> <li><strong>100+ para \u00e7ekme y\u00f6ntemi<\/strong> - kripto paralar, e-c\u00fczdanlar ve banka kartlar\u0131 dahil<\/li> <li><strong>Par\u00e7al\u0131 hisse senetleri mevcut<\/strong> - pahal\u0131 hisselere k\u00fc\u00e7\u00fck miktarlarla yat\u0131r\u0131m yap\u0131n<\/li> <\/ul> <p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc ve e\u011fitim kaynaklar\u0131, Immunocore Holdings plc (IMCR) hisseleri ve di\u011fer biyoteknoloji hisseleri nas\u0131l al\u0131n\u0131r \u00f6\u011frenen yeni ba\u015flayanlar i\u00e7in idealdir.<\/p> <h2>\ud83c\udf0d Immunocore 2025'te: Kanser Tedavisinde Devrim<\/h2> <p>Immunocore, \u00e7\u0131\u011f\u0131r a\u00e7an ImmTAX platformuyla imm\u00fcnoterapi yenili\u011finin \u00f6n saflar\u0131nda yer al\u0131yor. \u015eirketin \u00f6nc\u00fc \u00fcr\u00fcn\u00fc KIMMTRAK, 28 \u00fclkede metastatik uveal melanom i\u00e7in standart bak\u0131m haline geldi ve d\u00fcnya \u00e7ap\u0131nda 39 \u00fclkede onay ald\u0131.<\/p> <p>ImmTAX platformu t\u0131pta kuantum s\u0131\u00e7ramas\u0131d\u0131r - daha \u00f6nce geleneksel terapilere eri\u015filemeyen <strong>%90'a yak\u0131n hastal\u0131k hedefini<\/strong> hedefleyebilir. Bu mod\u00fcler sistem, ba\u011f\u0131\u015f\u0131kl\u0131k sistemini ya yukar\u0131 d\u00fczenleyebilir (kanser\/enfeksiyon hastal\u0131klar\u0131 i\u00e7in) ya da a\u015fa\u011f\u0131 d\u00fczenleyebilir (otoimm\u00fcn hastal\u0131klar i\u00e7in).<\/p> <p><strong>2025 e\u011flenceli bilgi<\/strong>: Immunocore teknolojisi 1990'larda Oxford \u00dcniversitesi ara\u015ft\u0131rmalar\u0131ndan do\u011fdu ve o zamandan beri Genentech, GSK ve Bill & Melinda Gates Vakf\u0131 gibi devlerle ortakl\u0131k kurdu. Genel merkezleri L'Or\u00e9al gibi parf\u00fcm p\u00fcsk\u00fcrten asans\u00f6rlere sahip olmayabilir ama milyonlarca hayat kurtarabilecek tedaviler geli\u015ftiriyorlar!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Immunocore Hissesi: G\u00fcncel Fiyat ve Piyasa Konumu<\/h2>\n<p>30 A\u011fustos 2025 itibar\u0131yla, Immunocore Holdings plc (IMCR) NASDAQ borsas\u0131nda <strong>32,65 $<\/strong> fiyatla i\u015flem g\u00f6r\u00fcyor. \u015eirket, dalgal\u0131 biyoteknoloji sekt\u00f6r\u00fcnde ola\u011fan\u00fcst\u00fc bir dayan\u0131kl\u0131l\u0131k g\u00f6stererek <strong>883 milyon $<\/strong> g\u00fc\u00e7l\u00fc nakit pozisyonunu korurken etkileyici gelir art\u0131\u015f\u0131 sa\u011flad\u0131.<\/p>\n<p><strong>Takviminize not edin: 5 Kas\u0131m 2025<\/strong>, IMCR yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in kesinlikle kritik bir tarih. \u015eirketin 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klad\u0131\u011f\u0131 g\u00fcn ve tarihsel olarak bu a\u00e7\u0131klamalar \u00f6nemli fiyat hareketlerine neden oluyor.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 IMCR Hissesini Nas\u0131l Hareket Ettirir<\/h3>\n<p>Immunocore, analist beklentilerini a\u015fma konusunda \u00fcn kazanm\u0131\u015ft\u0131r. 2025 2. \u00e7eyrek sonu\u00e7lar\u0131, hisse ba\u015f\u0131na -0,20 $ kazan\u00e7 g\u00f6stererek, -0,21 $ olan konsens\u00fcs tahminlerini 0,01 $ a\u015fm\u0131\u015ft\u0131r. Daha da etkileyici olan, \u00f6nceki \u00e7eyrekte hisse ba\u015f\u0131na 0,10 $ kazan\u00e7 sa\u011flayarak beklenen -0,35 $ de\u011ferini %128,57 olumlu s\u00fcrprizle a\u015fmalar\u0131d\u0131r (<a href=\"https:\/\/tickernerd.com\/stock\/imcr-forecast\/\">Tickernerd<\/a>).<\/p>\n<p>Desen a\u00e7\u0131k: Immunocore beklentileri a\u015ft\u0131\u011f\u0131nda, piyasa onlar\u0131 \u00f6d\u00fcllendiriyor. 2025 2. \u00e7eyrek geliri 130,65 milyon $&#8217;a ula\u015farak %30 y\u0131ll\u0131k art\u0131\u015f g\u00f6sterdi ve 122,96 milyon $ olan konsens\u00fcs tahminlerini ge\u00e7ti (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/IMCR\/earnings\/\">MarketBeat<\/a>).<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu ve Volatilite Analizi<\/h2>\n<p>Immunocore hisseleri son alt\u0131 ayda zorlu ama nihayetinde istikrarl\u0131 bir yol izledi. Hisse, <strong>52 haftal\u0131k 23,15 $ ile 39,33 $ aral\u0131\u011f\u0131nda<\/strong> i\u015flem g\u00f6rd\u00fc ve mevcut fiyat bu aral\u0131\u011f\u0131n ortalar\u0131na yak\u0131n konumda (<a href=\"https:\/\/www.macrotrends.net\/stocks\/charts\/IMCR\/immunocore-holdings\/stock-price-history\">Macrotrends<\/a>).<\/p>\n<p><strong>\u00d6nemli volatilite bilgileri:<\/strong><\/p>\n<ul>\n<li>G\u00fcnl\u00fck volatilite son hafta ortalamas\u0131 <strong>%2,47<\/strong><\/li>\n<li>Haftal\u0131k volatilite <strong>%4,5<\/strong> olup biyoteknoloji sekt\u00f6r ortalamas\u0131 %10,6&#8217;n\u0131n olduk\u00e7a alt\u0131ndad\u0131r<\/li>\n<li>Hisse son ayda sadece <strong>%47 ye\u015fil g\u00fcn<\/strong> g\u00f6sterirken fiyat volatilitesi %10,27&#8217;dir<\/li>\n<\/ul>\n<p>Baz\u0131 a\u015fa\u011f\u0131 y\u00f6nl\u00fc bask\u0131lara ra\u011fmen, IMCR <strong>35,63 $ teknik deste\u011fini<\/strong> hacim birikimine dayanarak koruyor ve test edilirse potansiyel al\u0131m f\u0131rsat\u0131 sunuyor (<a href=\"https:\/\/stockinvest.us\/stock\/IMCR\">StockInvest<\/a>).<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<h3>K\u0131sa Vadeli Projeksiyonlar (2025-2026)<\/h3>\n<p>2025 i\u00e7in analistler <strong>ortalama fiyat hedefi 47,23 $<\/strong> \u00f6ng\u00f6r\u00fcyor; iyimser senaryolar 65,65 $&#8217;a, muhafazakar tahminler ise 28,80 $ civar\u0131na ula\u015fabilir (<a href=\"https:\/\/stockscan.io\/stocks\/IMCR\/forecast\">Stockscan<\/a>). 7 uzman\u0131n olu\u015fturdu\u011fu mevcut analist konsens\u00fcs\u00fc <strong>&#8220;Al&#8221; notu ve ortalama hedef 57 $<\/strong> olup, mevcut seviyelerden %74,58 potansiyel y\u00fckseli\u015f anlam\u0131na geliyor.<\/p>\n<h3>Orta ve Uzun Vadeli Tahmin<\/h3>\n<ul>\n<li><strong>2026<\/strong>: 50-60 $ aral\u0131\u011f\u0131na do\u011fru b\u00fcy\u00fcme e\u011filiminin devam etmesi bekleniyor<\/li>\n<li><strong>2028<\/strong>: \u00dcr\u00fcn hatt\u0131 olgunla\u015ft\u0131k\u00e7a 70-85 $ aral\u0131\u011f\u0131na ula\u015fmas\u0131 \u00f6ng\u00f6r\u00fcl\u00fcyor<\/li>\n<li><strong>2030<\/strong>: Platform geni\u015flemesi ve pazar penetrasyonuna dayanarak 90,85 $ tahmin ediliyor<\/li>\n<\/ul>\n<p><strong>Sonu\u00e7: UZUN VADEL\u0130 G\u00dc\u00c7L\u00dc ALIM<\/strong>. G\u00fc\u00e7l\u00fc gelir art\u0131\u015f\u0131, geni\u015fleyen \u00fcr\u00fcn hatt\u0131 ve devasa hedef pazarlar IMCR&#8217;yi sab\u0131rl\u0131 sermaye i\u00e7in cazip bir f\u0131rsat haline getiriyor.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Y\u00fcksek RSI<\/strong>: Mevcut RSI14 de\u011feri <strong>81<\/strong> a\u015f\u0131r\u0131 al\u0131m ko\u015fullar\u0131n\u0131 g\u00f6steriyor<\/li>\n<li><strong>K\u00e2rl\u0131l\u0131k zorluklar\u0131<\/strong>: -0,41 negatif EPS ve -26,71 ileriye d\u00f6n\u00fck F\/K oran\u0131<\/li>\n<li><strong>Klinik deneme riskleri<\/strong>: Faz 3 denemeleri do\u011fas\u0131 gere\u011fi belirsizlik ta\u015f\u0131r<\/li>\n<li><strong>Reg\u00fclasyon engelleri<\/strong>: FDA onaylar\u0131 biyoteknolojide \u00f6ng\u00f6r\u00fclemez olabilir<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>Gelir patlamas\u0131<\/strong>: KIMMTRAK sat\u0131\u015flar\u0131 2. \u00e7eyrekte %30 y\u0131ll\u0131k art\u0131\u015fla 98,0 milyon $ oldu<\/li>\n<li><strong>Nakit kalesi<\/strong>: 883 milyon $ nakit rezervi 5+ y\u0131l finansman sa\u011fl\u0131yor<\/li>\n<li><strong>\u00dcr\u00fcn hatt\u0131 ilerlemesi<\/strong>: Faz 3 TEBE-AM denemesi 2026 ilk yar\u0131s\u0131nda tamamlanmaya uygun<\/li>\n<li><strong>Sekt\u00f6r r\u00fczgarlar\u0131<\/strong>: Kanser imm\u00fcnoterapisi pazar\u0131 y\u0131lda %15 b\u00fcy\u00fcyor<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %5 veya daha az\u0131n\u0131 temsil eden pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fc ile ba\u015flay\u0131n<\/li>\n<li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n<\/strong>: Zamanlama hatalar\u0131n\u0131 \u00f6nlemek i\u00e7in ayl\u0131k sabit tutarlarda yat\u0131r\u0131m yap\u0131n<\/li>\n<li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong>: Potansiyel giri\u015f noktalar\u0131 i\u00e7in 5 Kas\u0131m kazan\u00e7lar\u0131n\u0131 izleyin<\/li>\n<li><strong>Uzun vadeli d\u00fc\u015f\u00fcn\u00fcn<\/strong>: Biyoteknoloji yat\u0131r\u0131mlar\u0131 3-5 y\u0131l zaman ufku gerektirir<\/li>\n<\/ol>\n<p>Mizahi yorum: &#8220;IMCR ticareti yapmak klinik deneme izlemek gibidir &#8211; %90 bekleyi\u015f, %10 heyecan, ama i\u015fe yarad\u0131\u011f\u0131nda ger\u00e7ekten i\u015fe yarar!&#8221;<\/p>\n<h2>\u2705 Immunocore Holdings plc (IMCR) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NASDAQ eri\u015fimi ve makul \u00fccretler sundu\u011fundan emin olun<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>Genellikle kimlik ve adres kan\u0131t\u0131 gerektirir<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Fon yat\u0131r\u0131n<\/td>\n<td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>&#8220;IMCR&#8221; aramas\u0131 yap\u0131n<\/td>\n<td>\u015eirket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>\u0130nceleyin ve onaylay\u0131n<\/td>\n<td>Son i\u015flem \u00f6ncesi komisyon oranlar\u0131n\u0131 kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Pozisyonunuzu izleyin<\/td>\n<td>Stop-loss ve kar hedefleri belirleyin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Uygun?<\/h2>\n<p>Pocket Option, hisse senedi yat\u0131r\u0131m\u0131n\u0131 herkes i\u00e7in eri\u015filebilir k\u0131lar:<\/p>\n<ul>\n<li><strong>Minimum depozito sadece 5 $<\/strong> &#8211; stratejileri risksiz test etmek i\u00e7in m\u00fckemmel<\/li>\n<li><strong>1 dakikal\u0131k KYC s\u00fcreci<\/strong> &#8211; herhangi bir kimlik belgesi y\u00fckleyin ve hemen i\u015flem yapmaya ba\u015flay\u0131n<\/li>\n<li><strong>100+ para \u00e7ekme y\u00f6ntemi<\/strong> &#8211; kripto paralar, e-c\u00fczdanlar ve banka kartlar\u0131 dahil<\/li>\n<li><strong>Par\u00e7al\u0131 hisse senetleri mevcut<\/strong> &#8211; pahal\u0131 hisselere k\u00fc\u00e7\u00fck miktarlarla yat\u0131r\u0131m yap\u0131n<\/li>\n<\/ul>\n<p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc ve e\u011fitim kaynaklar\u0131, Immunocore Holdings plc (IMCR) hisseleri ve di\u011fer biyoteknoloji hisseleri nas\u0131l al\u0131n\u0131r \u00f6\u011frenen yeni ba\u015flayanlar i\u00e7in idealdir.<\/p>\n<h2>\ud83c\udf0d Immunocore 2025&#8217;te: Kanser Tedavisinde Devrim<\/h2>\n<p>Immunocore, \u00e7\u0131\u011f\u0131r a\u00e7an ImmTAX platformuyla imm\u00fcnoterapi yenili\u011finin \u00f6n saflar\u0131nda yer al\u0131yor. \u015eirketin \u00f6nc\u00fc \u00fcr\u00fcn\u00fc KIMMTRAK, 28 \u00fclkede metastatik uveal melanom i\u00e7in standart bak\u0131m haline geldi ve d\u00fcnya \u00e7ap\u0131nda 39 \u00fclkede onay ald\u0131.<\/p>\n<p>ImmTAX platformu t\u0131pta kuantum s\u0131\u00e7ramas\u0131d\u0131r &#8211; daha \u00f6nce geleneksel terapilere eri\u015filemeyen <strong>%90&#8217;a yak\u0131n hastal\u0131k hedefini<\/strong> hedefleyebilir. Bu mod\u00fcler sistem, ba\u011f\u0131\u015f\u0131kl\u0131k sistemini ya yukar\u0131 d\u00fczenleyebilir (kanser\/enfeksiyon hastal\u0131klar\u0131 i\u00e7in) ya da a\u015fa\u011f\u0131 d\u00fczenleyebilir (otoimm\u00fcn hastal\u0131klar i\u00e7in).<\/p>\n<p><strong>2025 e\u011flenceli bilgi<\/strong>: Immunocore teknolojisi 1990&#8217;larda Oxford \u00dcniversitesi ara\u015ft\u0131rmalar\u0131ndan do\u011fdu ve o zamandan beri Genentech, GSK ve Bill &#038; Melinda Gates Vakf\u0131 gibi devlerle ortakl\u0131k kurdu. Genel merkezleri L&#8217;Or\u00e9al gibi parf\u00fcm p\u00fcsk\u00fcrten asans\u00f6rlere sahip olmayabilir ama milyonlarca hayat kurtarabilecek tedaviler geli\u015ftiriyorlar!<\/p>\n"},"faq":[{"question":"Immunocore hisseleri nereden al\u0131nabilir?","answer":"Immunocore hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden IMCR sembol\u00fc ile al\u0131m yapabilirsiniz."},{"question":"Immunocore'nun b\u00fcy\u00fcme potansiyeli nedir?","answer":"Analistler 2025-2030 aras\u0131nda g\u00fc\u00e7l\u00fc b\u00fcy\u00fcme \u00f6ng\u00f6r\u00fcyor. 2025 i\u00e7in ortalama fiyat hedefi 47,23 $ olup, 2030'da 90,85 $ seviyesine ula\u015fmas\u0131 bekleniyor."},{"question":"Immunocore hissesi al\u0131rken nelere dikkat etmeliyim?","answer":"Y\u00fcksek RSI, klinik deneme riskleri ve reg\u00fclasyon engelleri gibi riskler vard\u0131r. Ayr\u0131ca, kazan\u00e7 raporlar\u0131 ve teknik destek seviyeleri takip edilmelidir."},{"question":"Yeni ba\u015flayan biri Immunocore hissesi al\u0131rken nas\u0131l bir strateji izlemeli?","answer":"K\u00fc\u00e7\u00fck pozisyonlarla ba\u015flay\u0131p, dolar maliyeti ortalamas\u0131 yaparak, fiyat uyar\u0131lar\u0131 kurarak ve uzun vadeli d\u00fc\u015f\u00fcnerek yat\u0131r\u0131m yapmak \u00f6nerilir."},{"question":"Pocket Option platformu Immunocore hissesi al\u0131m\u0131 i\u00e7in uygun mu?","answer":"Evet, Pocket Option d\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 KYC s\u00fcreci, \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi ve par\u00e7al\u0131 hisse imkan\u0131 ile yeni yat\u0131r\u0131mc\u0131lar i\u00e7in uygundur."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Immunocore hisseleri nereden al\u0131nabilir?","answer":"Immunocore hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden IMCR sembol\u00fc ile al\u0131m yapabilirsiniz."},{"question":"Immunocore'nun b\u00fcy\u00fcme potansiyeli nedir?","answer":"Analistler 2025-2030 aras\u0131nda g\u00fc\u00e7l\u00fc b\u00fcy\u00fcme \u00f6ng\u00f6r\u00fcyor. 2025 i\u00e7in ortalama fiyat hedefi 47,23 $ olup, 2030'da 90,85 $ seviyesine ula\u015fmas\u0131 bekleniyor."},{"question":"Immunocore hissesi al\u0131rken nelere dikkat etmeliyim?","answer":"Y\u00fcksek RSI, klinik deneme riskleri ve reg\u00fclasyon engelleri gibi riskler vard\u0131r. Ayr\u0131ca, kazan\u00e7 raporlar\u0131 ve teknik destek seviyeleri takip edilmelidir."},{"question":"Yeni ba\u015flayan biri Immunocore hissesi al\u0131rken nas\u0131l bir strateji izlemeli?","answer":"K\u00fc\u00e7\u00fck pozisyonlarla ba\u015flay\u0131p, dolar maliyeti ortalamas\u0131 yaparak, fiyat uyar\u0131lar\u0131 kurarak ve uzun vadeli d\u00fc\u015f\u00fcnerek yat\u0131r\u0131m yapmak \u00f6nerilir."},{"question":"Pocket Option platformu Immunocore hissesi al\u0131m\u0131 i\u00e7in uygun mu?","answer":"Evet, Pocket Option d\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 KYC s\u00fcreci, \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi ve par\u00e7al\u0131 hisse imkan\u0131 ile yeni yat\u0131r\u0131mc\u0131lar i\u00e7in uygundur."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Immunocore Holdings plc (IMCR) Hisseleri Nas\u0131l Al\u0131n\u0131r - Immunocore Holdings plc (IMCR) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-immunocore-holdings\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Immunocore Holdings plc (IMCR) Hisseleri Nas\u0131l Al\u0131n\u0131r - Immunocore Holdings plc (IMCR) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-immunocore-holdings\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-30T16:14:37+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-immunocore-holdings\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-immunocore-holdings\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Immunocore Holdings plc (IMCR) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Immunocore Holdings plc (IMCR) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-30T16:14:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-immunocore-holdings\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-immunocore-holdings\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-immunocore-holdings\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-immunocore-holdings\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-immunocore-holdings\/\",\"name\":\"Immunocore Holdings plc (IMCR) Hisseleri Nas\u0131l Al\u0131n\u0131r - Immunocore Holdings plc (IMCR) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-immunocore-holdings\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-immunocore-holdings\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"datePublished\":\"2025-08-30T16:14:37+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-immunocore-holdings\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-immunocore-holdings\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-immunocore-holdings\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-immunocore-holdings\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Immunocore Holdings plc (IMCR) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Immunocore Holdings plc (IMCR) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Immunocore Holdings plc (IMCR) Hisseleri Nas\u0131l Al\u0131n\u0131r - Immunocore Holdings plc (IMCR) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-immunocore-holdings\/","og_locale":"tr_TR","og_type":"article","og_title":"Immunocore Holdings plc (IMCR) Hisseleri Nas\u0131l Al\u0131n\u0131r - Immunocore Holdings plc (IMCR) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-immunocore-holdings\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-30T16:14:37+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-immunocore-holdings\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-immunocore-holdings\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Immunocore Holdings plc (IMCR) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Immunocore Holdings plc (IMCR) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-30T16:14:37+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-immunocore-holdings\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-immunocore-holdings\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-immunocore-holdings\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-immunocore-holdings\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-immunocore-holdings\/","name":"Immunocore Holdings plc (IMCR) Hisseleri Nas\u0131l Al\u0131n\u0131r - Immunocore Holdings plc (IMCR) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-immunocore-holdings\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-immunocore-holdings\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","datePublished":"2025-08-30T16:14:37+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-immunocore-holdings\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-immunocore-holdings\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-immunocore-holdings\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-immunocore-holdings\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Immunocore Holdings plc (IMCR) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Immunocore Holdings plc (IMCR) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":361122,"slug":"how-to-buy-immunocore-holdings","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Immunocore Holdings plc (IMCR) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Immunocore Holdings plc (IMCR)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-immunocore-holdings\/"},"pt_AA":{"locale":"pt_AA","id":361120,"slug":"how-to-buy-immunocore-holdings","post_title":"Como comprar a\u00e7\u00f5es da Immunocore Holdings plc (IMCR) - Investimento em a\u00e7\u00f5es da Immunocore Holdings plc (IMCR)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-immunocore-holdings\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/361124","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=361124"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/361124\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334072"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=361124"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=361124"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=361124"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}